Axcelis Technologies Inc.

▲ Bull Case

• ◆The 8-inch SiC wafer transition is a multi-year equipment replacement supercycle that has not yet begun in earnest, with every SiC fab building 200mm capacity requiring Purion Power Series+ tools, potentially driving revenue from ~$840M (FY2025) toward $1.2–1.4B by FY2028 and compressing multiples from 42x trough to 18–20x normalized.
• ◆HBM/AI memory demand provides a near-term earnings bridge while the SiC transition ramps, with Q1 2026 marking the first YoY revenue growth since the correction began, driven by memory capex from SK Hynix, Samsung, and Micron for NVIDIA and AMD AI accelerators.
• ◆Zero debt, aggressive buybacks reducing share count by 10.5% over 5 years without financial leverage, and durable gross margins create a compounding machine with $107–144M FCF at trough and normalized FCF approaching $150–160M on $1.1B revenue.

▼ Bear Case

• ◆China represents an estimated 30–40% of Axcelis's revenue, and further export controls targeting 300mm ion implanters in the U.S.-China semiconductor conflict could remove $150–200M in annual revenue with no near-term substitute, collapsing the stock to $55–75.
• ◆The SiC supercycle peaked in FY2023 and may not re-accelerate until 2028+ due to revised-down EV adoption rates and excess fab capacity, with 8-inch transition slow and meaningful volume ramp not projected until 2027–2028, putting the stock at $75–120 if de-rated to 25–30x on extended-cycle expectations.
• ◆The Veeco merger introduces binary regulatory risk and is value-dilutive regardless of outcome: SAMR approval means ~30% share count dilution for ACLS shareholders on an all-stock deal at depressed Veeco prices, while SAMR block creates 12–18 months of management distraction and $50–75M deal expense.

“The core debate is whether the FY2025 revenue trough ($839M) is a floor or a mid-decline plateau. Bulls cite Q1 2026 first positive YoY growth, HBM order pipeline visibility, 8-inch SiC qualification cycle starting, and management guidance suggesting trough confirmation. Bears cite China export control trajectory worsening, SiC over-equipment preventing replacement order velocity, Veeco merger uncertainty, consensus 2026 EPS of ~$2.86 vs. prior $4.39 implying no earnings recovery expected, and 23.6% short interest reflecting institutional skepticism. Secondary debate: ACLS at 20–24x normalized EBITDA deserves a premium to ONTO (~15x) but a discount to KLAC (~25–30x) given smaller scale and China exposure.”

• ◆Q2 2026 earnings beat (revenue >$215M, +10–15% stock impact, 55% probability)
• ◆First 8-inch SiC Purion Power Series+ order announcement (H2 2026, +15–25% impact, 40% probability)
• ◆China SAMR approves Veeco merger (H2 2026, +5–15% impact, 60% probability)
• ◆FY2026 guidance raise from management (Oct/Nov 2026, +10–20% impact, 40% probability)
• ◆HBM customer qualification announcement (H2 2026, +8–15% impact, 45% probability)

• ◆China export controls escalation removes 30–40% of revenue ($150–200M) with no near-term offset; highest magnitude risk (25% probability)
• ◆SiC cycle extension beyond 2027 delays FY2027 recovery, invalidating principal valuation thesis; stock de-rates to $75–120 range if extended
• ◆Veeco SAMR block (20–25% probability) creates management distraction, $50–75M deal expense, and stock re-rating to pre-announcement standalone value
• ◆SiC customer concentration: Wolfspeed financial distress could remove 10–15% of SiC system orders
• ◆HBM capex plateau if AI infrastructure spending moderates in H2 2026, weakening near-term earnings bridge